|Articles|July 1, 2009

Lessons Learned for IRBs

After the Coast Hearing, IRBs Should Prepare for More Scrutiny by Focusing on Training, Education, and SOPs

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Lessons Learned for IRBs

Related Content

What Program-Level Recruitment Requires from Sponsors Operationally

ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

Why Rebuilding Patient Pipelines from Scratch for Every Study Has to Stop

Bringing the Voice of Clinical Practice and Patients into Drug Development

Trending on Applied Clinical Trials Online

ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

Bringing the Voice of Clinical Practice and Patients into Drug Development